Skip to content

Cognitive behavioural treatment for persistent positive symptoms in psychotic disorders

-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN29242879
Enrollment
260
Registered
2007-01-26
Start date
2007-01-01
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychotic disorders (schizophrenia, schizophreniform, schizoaffective and delusional disorders) Mental and Behavioural Disorders Psychotic disorders (schizophrenia, schizophreniform, schizoaffective and delusional disorders)

Interventions

Cognitive Behavioural Treatment versus Supportive Therapy

Sponsors

University Hospital Tuebingen (Germany)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Schizophrenia, schizophreniform, schizoaffective, delusional disorders (according to Diagnostic and Statistical Manual of Mental Disorders - fourth edition [DSM-IV]) 2. Score of four or more on the Positive and Negative Syndrome Scale (PANSS)-items ?delusions? or ?hallucinations? 3. Presence of these symptoms for at least three months

Exclusion criteria

Exclusion criteria: 1. Substance abuse or substance dependence as primary clinical problem 2. Organic brain disease

Design outcomes

Primary

MeasureTime frame
Primary endpoint for efficacy: PANSS positive syndrome (sum of items P1-P7), assessed post treatment (T9).

Secondary

MeasureTime frame
Key secondary endpoints: 1. Additional symptom ratings (e.g. PSYRATS) 2. Social functioning 3. Illness related events 4. Quality of life 5. Questionnaires about self schemata and interpersonal schemata 6. Direct and indirect costs Assessment of safety: 1. Death 2. Suicidal behaviour 3. Severe depressive symptom exacerbation

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 28, 2026